The emerging role of high-dose-rate brachytherapy for prostate cancer.
暂无分享,去创建一个
[1] C C Ling,et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.
[2] L Souhami,et al. Controversies in prostate cancer radiotherapy: consensus development. , 2001, The Canadian journal of urology.
[3] Jian Z. Wang,et al. The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us? , 2003 .
[4] Y. Yoshioka,et al. High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial. , 2000, International journal of radiation oncology, biology, physics.
[5] T. Mate,et al. High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report. , 1998, International journal of radiation oncology, biology, physics.
[6] D. Baltas,et al. 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Glen Gejerman,et al. Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. , 2004, International journal of radiation oncology, biology, physics.
[8] G. Gustafson,et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. , 2004, The Journal of urology.
[9] J. Pouliot,et al. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. , 2004, International journal of radiation oncology, biology, physics.
[10] K. Johansson,et al. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] S J Damore,et al. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. , 2000, International journal of radiation oncology, biology, physics.
[12] J. Pouliot,et al. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. , 2004, International journal of radiation oncology, biology, physics.
[13] D. Brenner,et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue , 2002 .
[14] A. Nahum,et al. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the α/β ratio , 2003 .
[15] I. Hsu,et al. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation. , 2000, International journal of radiation oncology, biology, physics.
[16] S. Nag,et al. A simple method of obtaining equivalent doses for use in HDR brachytherapy. , 2000, International journal of radiation oncology, biology, physics.
[17] High‐dose rate iridium‐192 brachytherapy and external beam radiation therapy for prostate cancer with or without androgen ablation , 2004, International journal of urology : official journal of the Japanese Urological Association.
[18] Jose A Gonzalez,et al. No apparent benefit at 5 years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose. , 2003, The Journal of urology.
[19] P. Novaes,et al. Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer. , 2004, The Journal of urology.
[20] J. Cherlow,et al. High-dose-rate brachytherapy in the treatment of carcinoma of the prostate. , 2001, Cancer control : journal of the Moffitt Cancer Center.
[21] Y. Jo,et al. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. , 2004, International journal of radiation oncology, biology, physics.
[22] P. Hoskin,et al. High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] R. Galalae,et al. Fractionated perineal high-dose-rate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: is lymph node sampling necessary? , 2003, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.
[24] L. Potters,et al. Permanent prostate brachytherapy in men with clinically localised prostate cancer. , 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).
[25] M. J. Curran,et al. Treatment of high-grade low-stage prostate cancer by high-dose-rate brachytherapy. , 2000, Journal of endourology.
[26] A. Wallgren,et al. Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] M. Kattan,et al. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] D. Baltas,et al. 3-D Conformal HDR Brachytherapy as Monotherapy for Localized Prostate Cancer , 2004, Strahlentherapie und Onkologie.
[29] G. Gustafson,et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report. , 2001, International journal of radiation oncology, biology, physics.
[30] George Starkschall,et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.
[31] David J Brenner,et al. What hypofractionated protocols should be tested for prostate cancer? , 2002, International journal of radiation oncology, biology, physics.
[32] High dose rate brachytherapy of localized prostate cancer. , 2002 .
[33] D. Demanes,et al. High dose rate prostate brachytherapy: the California Endocurietherapy (CET) method. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[34] M. Johnston,et al. Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[35] Chris Mitchell,et al. Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. , 2002, International Journal of Radiation Oncology, Biology, Physics.
[36] D. Ash,et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[37] P. Novaes,et al. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[38] T. Mate,et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. , 2004, International journal of radiation oncology, biology, physics.
[39] New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[40] C. N. Coleman,et al. MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. , 2004, International journal of radiation oncology, biology, physics.
[41] Rick Chappell,et al. Is α/β for prostate tumors really low? , 2001 .